Allarity Therapeutics, Inc. (ALLR) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$14.82M | +14.6% |
| 2024 | -$17.35M | -36.1% |
| 2023 | -$12.74M | +24.2% |
| 2022 | -$16.82M | -13.0% |
| 2021 | -$14.89M | -105.3% |
| 2020 | -$7.25M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$14.82M | +14.6% |
| 2024 | -$17.35M | -36.1% |
| 2023 | -$12.74M | +24.2% |
| 2022 | -$16.82M | -13.0% |
| 2021 | -$14.89M | -105.3% |
| 2020 | -$7.25M | — |